Song, Shiyi
Zhang, Xiuli
Cui, Pin
He, Weihuang
Zhou, Jiyuan
Wang, Shubing
Xiong, Yong
Xu, Shu
Lin, Xiaohui
Huang, Guozeng
Tan, Xiaohua
Xu, Qinglong
Liu, Yongling
Li, Qingqun
Yuan, Kehua
Feng, Mingji
Lai, Hanming
Yang, Hui
Zhang, Shaorong
Funding for this research was provided by:
Shenzhen Rapha Biotechnology Incorporate R&D Clinical Study Fund (RFCS20210701001, RFCS20210701001, RFCS20210701001, RFCS20210701001)
Shenzhen Science and Technology Innovation Commission Project (KCXFZ20200201101050887)
Shenzhen San-Ming Project of Medicine (SZSM2022-11036)
Article History
Received: 2 December 2024
Accepted: 29 May 2025
First Online: 5 June 2025
Declarations
:
: The protocol obtained review and approval from the Ethics and Scientific Committee of the Shenzhen Traditional Chinese Medicine Hospital (No. (2018)58), Peking University Shenzhen Hospital (NO. 2021–075), and Shenzhen GuangMing District People’s Hospital (NO. LL-KT-2022053). All participants provided written informed consent for the scientific use of their clinical data and sample.
: Not applicable.
: The authors declare no competing interests.